Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3
Pathology and Oncology Research · 2025
DOI: 10.3389/pore.2025.1612095 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathology and Oncology Research, 2025. Verfasst von Gábor Szalóki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Biomarkers, Tumor, CD3 Complex, Leukocyte Common Antigens, Lymphoma, T-Cell, Peripheral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peripheral T-cell lymphomas (PTCLs) are a group of non-Hodgkin lymphomas originating from mature T-lymphocytes. Despite encompassing several well-defined entities, about 25% of the PTCLs do not fulfill the requirements of any of the subcategories. These diseases are classified as PTCL, not otherwise specified (PTCL, NOS), and often associated with poor prognosis. Hereby we present a case of a female patient, diagnosed with PTCL, NOS from her skin biopsy specimen. Besides histology and immunohistochemistry, flow cytometry was used for phenotyping and staging (peripheral blood, bone marrow). Pathologic T-cells were found in all the investigated tissues, with a very unusual CD45 negative and surface CD3 dim immunophenotype. For proper differential diagnosis, we determined several markers with immunohistochemistry (CD3, CD4, CD7, CD8, CD30, PD1, Ki-67) and flow cytometry: (CD2, cytoplasmic CD3, surface CD3, CD4, CD5, CD7, CD8, CD9, CD10, CD19, CD20, CD26, CD34, CD38, CD45, CD48, CD56, CD99, CD123, surface TRBC1, cytosplasmic TRBC1, surface TRBC2, cytoplasmic TRBC2, MPO, TdT, Igκ, Igλ). Here we discuss the difficulties of the differential diagnostic process and highlight some potential pitfalls of flow cytometric analysis of the pathologic T-cells with such a rare immunophenotype. Despite several determined markers, the disease characteristics did not meet the criteria of any PTCL subtype, therefore the diagnosis remained PTCL, NOS. Due to the aggressive course of the disease, we lost the patient within 1 year after the diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
- Department of Internal Medicine and Haematology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Zitieren
APA
Szalóki, G., Szepesi, Á., Tárkányi, I., Márk, Á., Kriston, C., Hunyadi, A., Mózes, R., & Barna, G. (2025). Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3. Pathology and Oncology Research. https://doi.org/10.3389/pore.2025.1612095
Vancouver
Szalóki G, Szepesi Á, Tárkányi I, Márk Á, Kriston C, Hunyadi A, et al. Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3. Pathology and Oncology Research. 2025. doi:10.3389/pore.2025.1612095
BibTeX
@article{Szalki2025,
author = {Szalóki, Gábor and Szepesi, Ágota and Tárkányi, Ilona and Márk, Ágnes and Kriston, Csilla and Hunyadi, Anna and Mózes, Réka and Barna, Gábor},
title = {Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3},
journal = {Pathology and Oncology Research},
year = {2025},
doi = {10.3389/pore.2025.1612095}
}
EUVIMED